knowledge -WSS

knowledge

author：hotspot 2025-09-28 00:48:15 - browse：8415

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New CMS data security rules will hurt Medicare, Medicaid research

WSS

How dance can help nurses traumatized by Covid

FDA approves RSV monoclonal antibody for infants, toddlers

Medicare Advantage enrollment hits roughly 33.4 million

Medicare to cover more brain scans for Alzheimer’s patients

Obamacare plans could cover weight loss drugs

As AI regulations shape up, health tech startups beg for clarity

explore

knowledge

entertainment

Medical records are filled with copy

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Duchenne breakthrough therapy leaves behind pioneering families

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In early work, researchers turn to CRISPR to treat Alzheimer's

Walensky prepares to leave CDC — and Congress — behind

MD Anderson's Padmanee Sharma responds to research credit suit

Walensky prepares to leave CDC — and Congress — behind

Cosmetics set for new safety regulation. Why the industry is on board

entertainment

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Weight loss drugs aren’t covered by Obamacare. That may change

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

leisure time

focus

explore

entertainment